Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.

[1]  M. Schulze,et al.  Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis , 2016, European journal of preventive cardiology.

[2]  D. Hu,et al.  Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis , 2015, Hormone and Metabolic Research.

[3]  F. Azizi,et al.  Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study. , 2015, Atherosclerosis.

[4]  F. Hosseinpanah,et al.  Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study , 2014, International Journal of Obesity.

[5]  A. Ghasemi,et al.  Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. , 2014, Clinical biochemistry.

[6]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[7]  C. Gutiérrez‐Repiso,et al.  Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. , 2013, The Journal of clinical endocrinology and metabolism.

[8]  F. Hosseinpanah.  Which One Is More Important, Obesity or Cardio Metabolic Risk Factors? , 2012, International journal of endocrinology and metabolism.

[9]  G. Musso,et al.  Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort. , 2012, The American journal of clinical nutrition.

[10]  Mimi Y. Kim,et al.  Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals , 2012, Obesity.

[11]  F. Azizi,et al.  Evaluation of Cause of Deaths' Validity Using Outcome Measures from a Prospective, Population Based Cohort Study in Tehran, Iran , 2012, PloS one.

[12]  C. Stefanadis,et al.  Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. , 2011, Journal of the American College of Cardiology.

[13]  P. Nilsson,et al.  Metabolic normality in overweight and obese subjects. Which parameters? Which risks? , 2011, International Journal of Obesity.

[14]  K. Matthews,et al.  Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). , 2011, Atherosclerosis.

[15]  F. Azizi,et al.  Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). , 2011, The American journal of cardiology.

[16]  J. Cleeman,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Forceon Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World HeartFederation; International Atherosclerosis Society; and International Asso , 2010 .

[17]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[18]  A. Zabetian,et al.  Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population , 2009, International Journal of Obesity.

[19]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[20]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[21]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.

[22]  M. Forouzanfar,et al.  First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East , 2009, Diabetes Care.

[23]  Farzad Hadaegh,et al.  Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II , 2009, Trials.

[24]  D. Levy,et al.  Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity , 2008, Diabetes Care.

[25]  Cathy Nonas,et al.  Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association , 2007, Obesity.

[26]  D. Allison,et al.  Waist Circumference and Cardiometabolic Risk , 2007, Diabetes Care.

[27]  Ralph B D'Agostino,et al.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  D. Chisholm,et al.  The metabolically obese, normal-weight individual revisited. , 1998, Diabetes.

[29]  Lewis H Kuller,et al.  Development of Questionnaire to Examine Relationship of Physical Activity and Diabetes in Pima Indians , 1990, Diabetes Care.

[30]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.

[31]  B E Ainsworth,et al.  Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. , 1993, Medicine and science in sports and exercise.